TAYLOR REHFUSS: Open Payments
NPI 1174167878 · ASHBURN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,058 in 216 payments from 22 companies in 2025. Trend: 2023 $3,432 · 2024 $3,670 · 2025 $4,058
Food & beverage: $3,854Education: $204
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $552 |
| GENZYME CORPORATION | 13 | $381 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $378 |
| Novartis Pharmaceuticals Corporation | 17 | $350 |
| ABBVIE INC. | 17 | $311 |
| Regeneron Healthcare Solutions, Inc. | 12 | $301 |
| Incyte Corporation | 16 | $282 |
| Arcutis Biotherapeutics, Inc. | 18 | $218 |
| UCB, Inc. | 10 | $211 |
| Medimetriks Pharmaceuticals, Inc. | 12 | $204 |
Products named: DUPIXENT, TREMFYA, ILUMYA, OPZELURA, SKYRIZI, Zoryve, Bimzelx, COSENTYX.
Industry payments across VA — which companies pay providers there.
